Aklog Lishan bought LUCD
February 20, 2026 · Form 4 insider transaction
Aklog Lishan bought 2,170,000 shares of Lucid Diagnostics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,170,000
Price
$0.00
Total value
N/A
InsiderAklog Lishan
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 20, 2026
Filing dateFebruary 24, 2026
Shares owned after3,636,627
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.